Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
3 other identifiers
observational
11
1 country
1
Brief Summary
OBJECTIVES: I. Determine the pattern of immunologic reconstitution in patients with T-cell compromise due to DiGeorge syndrome or velocardiofacial syndrome. II. Determine any correlation between immunologic function in these patients and chromosome 22 deletion breakpoints. III. Determine presence of sustained immunologic compromise in older patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1995
CompletedFirst Submitted
Initial submission to the registry
April 6, 2000
CompletedFirst Posted
Study publicly available on registry
April 7, 2000
CompletedJune 24, 2005
December 1, 2003
April 6, 2000
June 23, 2005
Conditions
Keywords
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kathleen E. Sullivan
Children's Hospital of Philadelphia
Study Design
- Study Type
- observational
- Observational Model
- NATURAL HISTORY
- Sponsor Type
- NIH
Study Record Dates
First Submitted
April 6, 2000
First Posted
April 7, 2000
Study Start
January 1, 1995
Last Updated
June 24, 2005
Record last verified: 2003-12